Kay MA - Search Results

1

Heterotopically transplanted hepatocyte survival depends on extracellular matrix components.

Ohashi K, Kay MA, Kuge H, Yokoyama T, Kanehiro H, Hisanaga M, Ko S, Nagao M, Sho M, Nakajima Y. Ohashi K, et al. Among authors: kay ma. Transplant Proc. 2005 Dec;37(10):4587-8. doi: 10.1016/j.transproceed.2005.11.049. Transplant Proc. 2005. PMID: 16387176

2

Stability and repeat regeneration potential of the engineered liver tissues under the kidney capsule in mice.

Ohashi K, Kay MA, Yokoyama T, Kuge H, Kanehiro H, Hisanaga M, Ko S, Nakajima Y. Ohashi K, et al. Among authors: kay ma. Cell Transplant. 2005;14(9):621-7. doi: 10.3727/000000005783982620. Cell Transplant. 2005. PMID: 16405072 Free article.

3

Extracellular matrix component cotransplantation prolongs survival of heterotopically transplanted human hepatocytes in mice.

Ohashi K, Kay MA. Ohashi K, et al. Among authors: kay ma. Transplant Proc. 2004 Oct;36(8):2469-70. doi: 10.1016/j.transproceed.2004.07.072. Transplant Proc. 2004. PMID: 15561284 No abstract available.

4

cMet activation allows persistent engraftment of ectopically transplanted xenogenic human hepatocytes in mice.

Ohashi K, Meuse L, Schwall R, Kay MA. Ohashi K, et al. Among authors: kay ma. Transplant Proc. 2001 Feb-Mar;33(1-2):587-8. doi: 10.1016/s0041-1345(00)02154-0. Transplant Proc. 2001. PMID: 11266970 No abstract available.

5

Liver tissue engineering at extrahepatic sites in mice as a potential new therapy for genetic liver diseases.

Ohashi K, Waugh JM, Dake MD, Yokoyama T, Kuge H, Nakajima Y, Yamanouchi M, Naka H, Yoshioka A, Kay MA. Ohashi K, et al. Among authors: kay ma. Hepatology. 2005 Jan;41(1):132-40. doi: 10.1002/hep.20484. Hepatology. 2005. PMID: 15619229

6

Hepatocyte transplantation: clinical and experimental application.

Ohashi K, Park F, Kay MA. Ohashi K, et al. Among authors: kay ma. J Mol Med (Berl). 2001 Nov;79(11):617-30. doi: 10.1007/s001090100260. J Mol Med (Berl). 2001. PMID: 11715065 Review.

7

Role of hepatocyte direct hyperplasia in lentivirus-mediated liver transduction in vivo.

Ohashi K, Park F, Kay MA. Ohashi K, et al. Among authors: kay ma. Hum Gene Ther. 2002 Mar 20;13(5):653-63. doi: 10.1089/10430340252837242. Hum Gene Ther. 2002. PMID: 11916488

8

The effect of age on hepatic gene transfer with self-inactivating lentiviral vectors in vivo.

Park F, Ohashi K, Kay MA. Park F, et al. Among authors: kay ma. Mol Ther. 2003 Aug;8(2):314-23. doi: 10.1016/s1525-0016(03)00169-2. Mol Ther. 2003. PMID: 12907154 Free article.

9

Donor-derived, liver-specific protein expression after bone marrow transplantation.

Jenkins DD, Streetz K, Tataria M, Sahar D, Kurobe M, Longaker MT, Kay MA, Sylvester KG. Jenkins DD, et al. Among authors: kay ma. Transplantation. 2004 Aug 27;78(4):530-6. doi: 10.1097/01.tp.0000130180.42573.b1. Transplantation. 2004. PMID: 15446311

10

Therapeutic levels of human factor VIII and IX using HIV-1-based lentiviral vectors in mouse liver.

Park F, Ohashi K, Kay MA. Park F, et al. Among authors: kay ma. Blood. 2000 Aug 1;96(3):1173-6. Blood. 2000. PMID: 10910939 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

307 results

Search Page

Filters